Comments
Loading...

Nektar Therapeutics (NKTR) Stock Price, Quote, News & History

NKTRNASDAQ
Logo brought to you by Benzinga Data
$53.30
-1.40-2.56%
At close: Dec 15, 4:00 PM EST
$58.80
5.5010.32%
After Hours: 7:59 PM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
Jun
1
Jul
2
Sep
2
Nov
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$54.01
Close
$53.30
Volume / Avg.
576.29K / 843.92K
Day Range
$52.01 - $54.20
52 Wk Range
6.48 - 66.92
Market Cap
$1.20B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
9.1%
Days to Cover
2.94

About

Sector
Health Care
Industry
Pharmaceuticals
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the fiel...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NKTR
TBPH

FAQ

Q

How do I buy Nektar Therapeutics (NKTR) stock?

A

You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Nektar Therapeutics (NKTR) competitors?

Q

What is the forecast, or price target, for Nektar Therapeutics (NKTR) stock?

A

Nektar Therapeutics has a consensus price target of $52.36.

Q

What is the current price for Nektar Therapeutics (NKTR)?

A

The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $58.8 last updated December 15, 2025 at 7:59 PM EST.

Q

Does Nektar Therapeutics (NKTR) pay a dividend?

A

There are no upcoming dividends for Nektar Therapeutics.

Q

When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?

A

Nektar Therapeutics does not have any upcoming earnings scheduled.

Q

Is Nektar Therapeutics (NKTR) going to split?

A

There is no upcoming split for Nektar Therapeutics.

Q

What sector and industry does Nektar Therapeutics (NKTR) operate in?

A

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.